Medical Disorders
Resources
Basic InformationLookupsLatest News
Obesity More Deadly for Men Than Women When COVID StrikesReal-World Studies Show Pfizer Vaccine Shields Against COVID Variants1 in 4 U.S. Teens Has Had a Concussion: StudyWhat's the Right Amount of Sleep for a Healthy Heart?U.S. COVID Outlook Shows Big Improvement by July'Prediabetes' Raises Odds for Heart Attack, StrokeA Vitamin Could Be Key to Women's Pain After Knee ReplacementBiden Sets New Goal of Vaccinating 70% of Americans by July 4Wildfires Are Changing the Seasonal Air Quality of the U.S. WestMany Americans Wrong About Sun's Skin Cancer Dangers: PollNot Just About Antibodies: Why mRNA COVID Vaccines May Shield From VariantsYou Got Your COVID Shot: What to Do With That Vaccine CardFDA Plans to OK Pfizer Vaccine for Those Aged 12 and UpAHA News: As Pre-Pandemic Activities Return, So Does AnxietyCOVID Anxieties Still High for Americans: PollCOVID Vaccination in Pregnancy May Pass Helpful Antibodies to BabyWhy U.S. Hispanics Got COVID at Higher Rates: Their JobsHerd Immunity for Americans May Be an Elusive Goal, Experts SayUrgent Care or the ER? Which Should You Choose?Needle Anxiety Behind J&J COVID Vaccine Reaction Clusters: Study1 in 5 Patients on Kidney Dialysis Say No to COVID-19 Vaccine: StudyYoung, Immune-Compromised Patients Are Hotspots for Coronavirus Mutations: StudyCOVID Deaths Continue to Decline in U.S.Researchers Seek Antiviral Pill That Would Ease COVID SeverityAHA News: Take Stock of Your Health With This Post-Lockdown ChecklistPoll Reveals Who's Most Vaccine-Hesitant in America and WhyGood Stroke Recovery May Depend on Your ZIP Code: StudyNew Advice for Blood Pressure That's a Bit Too HighMany U.S. Colleges Will Mandate Vaccines on Campus Next Fall: SurveyPfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at SecondAbout 1 in 7 Who Get Pfizer Vaccine Will Have Any 'Systemic' Side Effect: StudyPolls Find Most U.S. Young People Take COVID Threat SeriouslyAHA News: Experts Remain Confident About Vaccine Safety MonitoringNothing to Sniff at: Depression Common for People With COVID-Linked Smell LossHead Injury, Alzheimer's Appear to Affect Brain in Similar WaysCDC Says Vaccinated Can Shed Masks Outside, Except in CrowdsCOVID-19 Could Raise Odds for Heart Failure, Even in Those With No Prior Heart RiskU.S. to Share Up to 60 Million Doses of AstraZeneca Vaccine With Other CountriesLow Risk of Mom Passing COVID to NewbornThese Factors Could Lead to a Real Pain in the NeckWhy COVID Infection Raises Risks in PregnancyNew Drug May Be Better Psoriasis TreatmentMillions of Americans Have Missed Their Second COVID Vaccine Dose: CDCIs a Cheap 'Universal' Coronavirus Vaccine on the Way?Vertigo: A Common Symptom With Many Different CausesFDA Moves to Resume Use of J&J COVID Vaccine'Garage Lab' Vape Products May Be Driving Lung Injury in Rural AppalachiaNBA Study Shows Post-COVID Viral Transmission Rare, Even With Positive TestCDC Decision on Johnson & Johnson Vaccine Pause Expected FridayAHA News: How to Make Sure Everyone Gets a Fair Shot at the COVID-19 Vaccine
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Young, Immune-Compromised Patients Are Hotspots for Coronavirus Mutations: Study

HealthDay News
by Robert Preidt
Updated: Apr 30th 2021

new article illustration

FRIDAY, April 30, 2021 (HealthDay News) -- COVID-19 infections may last longer in young people with weakened immune systems, and that extended period could lead to more mutations in SARS-CoV-2, according to the authors of a new case study.

The study included two children and a young adult who had weakened immune systems due to treatment for acute lymphoblastic leukemia. For months, they tested positive for SARS-CoV-2, the virus that causes COVID-19.

Most people are infectious for only about 10 days after first showing COVID-19 symptoms, the Children's Hospital Los Angeles researchers noted.

The investigators said their study — published online April 26 in the journal EBioMedicine — is the first report of prolonged SARS-CoV-2 infection in kids or young adults.

"It's significant that these patients continued to have active symptoms and active infections for such a long time," said study co-author Jennifer Dien Bard, director of the hospital's Clinical Microbiology and Virology Laboratory.

"The large number of pediatric and adult patients receiving cancer therapy and being actively screened for the virus leads us to conclude that this is a rare occurrence but one that could have public health implications," she said in a hospital news release.

SARS-CoV-2 mutates about once or twice a month, so a long period of infection raises concerns about more viral mutations, Dien Bard explained.

Most mutations don't affect how the virus behaves or the disease it causes, but some may change how the virus acts. For example, the B.1.1.7 variant has 17 mutations and is believed to be more infectious than other virus variants.

Dien Bard said some evidence suggests the B.1.1.7 variant may have originated in a person who was immunocompromised and consistently infected with SARS-CoV-2.

But months-long infections are rare even in patients whose immune systems are compromised, the researchers noted.

"We have had many other immunocompromised patients who have not experienced these prolonged infections, but it's something to be aware of, and hospitals may want to consider changing infection control policies to address this particular special population," Dien Bard said.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 and people with certain medical conditions.

SOURCE: Children's Hospital Los Angeles, news release, April 28, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net